These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 33636990)

  • 1. Peripheral edema: An easily overlooked side effect of long-acting injectable paliperidone.
    Ho YC; Hu LY; Liou YJ
    Aust N Z J Psychiatry; 2021 Oct; 55(10):1023. PubMed ID: 33636990
    [No Abstract]   [Full Text] [Related]  

  • 2. Angioedema Associated With Long-Acting Injectable Paliperidone Palmitate: A Case Report.
    Papadopoulou A; Gkikas K; Efstathiou V; Gkikas I; Kokoris S; Lagari V; Papageorgiou C; Douzenis A; Siafakas N; Rizos EN
    J Clin Psychopharmacol; 2017 Dec; 37(6):730-732. PubMed ID: 29028688
    [No Abstract]   [Full Text] [Related]  

  • 3. Atypical Neuroleptic Malignant Syndrome Associated With Paliperidone Long-Acting Injection: A Case Report.
    Langley-DeGroot M; Joshi Y; Lehman D; Rao S
    J Clin Psychopharmacol; 2016 Jun; 36(3):277-9. PubMed ID: 27043124
    [No Abstract]   [Full Text] [Related]  

  • 4. A qualitative study of patient experience when switching from paliperidone palmitate once monthly (PP1M) to paliperidone palmitate three monthly (PP3M) long-acting injectable antipsychotic.
    Lai JK; Margolese HC
    Schizophr Res; 2019 Feb; 204():443-444. PubMed ID: 30241989
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of paliperidone palmitate one-month formulation on relapse prevention in patients with schizophrenia: A post-hoc analysis of a one-year, open-label study stratified by medication adherence.
    Si T; Li N; Lu H; Cai S; Zhuo J; Correll CU; Zhang L; Feng Y
    J Psychopharmacol; 2018 Jun; 32(6):691-701. PubMed ID: 29764266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Acting Injectable Paliperidone Palmitate: A Review of Efficacy and Safety.
    Morris MT; Tarpada SP
    Psychopharmacol Bull; 2017 May; 47(2):42-52. PubMed ID: 28626271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paliperidone and Edema.
    Frankenburg FR; Malvesti S
    J Clin Psychopharmacol; 2022 Mar-Apr 01; 42(2):225-226. PubMed ID: 34176871
    [No Abstract]   [Full Text] [Related]  

  • 8. Mortality rate is associated with paliperidone palmitate, risperidone long-acting injection, and oral paliperidone administration.
    Suzuki H; Hibino H; Inoue Y; Takaya A
    Asian J Psychiatr; 2018 Jun; 35():28. PubMed ID: 29751217
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of Paliperidone Palmitate and Second-Generation Oral Antipsychotics in Terms of Medication Adherence, Side Effects, and Quality of Life.
    Sağlam Aykut D
    J Clin Psychopharmacol; 2019; 39(1):57-62. PubMed ID: 30566417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of tardive dystonia associated with long-acting injectable paliperidone palmitate.
    Ma CH; Chien YL; Liu CC; Chen IM; Lin CH
    Eur Neuropsychopharmacol; 2016 Jul; 26(7):1251-2. PubMed ID: 27130697
    [No Abstract]   [Full Text] [Related]  

  • 11. Paliperidone palmitate: effectiveness, safety, and the use for treatment of schizophrenia.
    Jarema M; Bieńkowski P; Heitzman J; Parnowski T; Rybakowski J
    Psychiatr Pol; 2017 Feb; 51(1):7-21. PubMed ID: 28455891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost Effectiveness of Paliperidone Long-Acting Injectable Versus Other Antipsychotics for the Maintenance Treatment of Schizophrenia in France.
    Druais S; Doutriaux A; Cognet M; Godet A; Lançon C; Levy P; Samalin L; Guillon P
    Pharmacoeconomics; 2016 Apr; 34(4):363-91. PubMed ID: 26883132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Onset of efficacy and tolerability following the initiation dosing of long-acting paliperidone palmitate: post-hoc analyses of a randomized, double-blind clinical trial.
    Bossie CA; Sliwa JK; Ma YW; Fu DJ; Alphs L
    BMC Psychiatry; 2011 May; 11():79. PubMed ID: 21569242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paliperidone for the treatment of schizophrenia and schizoaffective disorders - a drug safety evaluation.
    Mauri MC; Reggiori A; Paletta S; Di Pace C; Altamura AC
    Expert Opin Drug Saf; 2017 Mar; 16(3):365-379. PubMed ID: 28140680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperprolactinemia in psychotic patients treated in monotherapy with long-acting injectable antipsychotics.
    Bonete Llácer JM; Martínez Hortelano A; Richart Albelda B
    Int J Psychiatry Clin Pract; 2019 Sep; 23(3):189-193. PubMed ID: 30848967
    [No Abstract]   [Full Text] [Related]  

  • 16. Paliperidone palmitate three-month depot formulation: a helpful innovation with practical pitfalls.
    Hope JD; Keks NA
    Australas Psychiatry; 2018 Apr; 26(2):206-209. PubMed ID: 29359582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The current data on the 3-month paliperidone palmitate formulation for the treatment of schizophrenia.
    Bioque M; Bernardo M
    Expert Opin Pharmacother; 2018 Oct; 19(14):1623-1629. PubMed ID: 30244607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal and life-threatening ADRs associated with paliperidone palmitate: an observational study in the French pharmacovigilance database.
    Boels D; Mahé J; Olry A; Citterio-Quentin A; Moragny J; Jolliet P
    Clin Toxicol (Phila); 2021 Sep; 59(9):786-793. PubMed ID: 33555955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective Analysis of the Effectiveness and Tolerability of Long-Acting Paliperidone Palmitate Antipsychotic in Adolescent First-Episode Schizophrenia Patients.
    Petrić D; Rački V; Gačo N; Kaštelan A; Graovac M
    J Child Adolesc Psychopharmacol; 2019 Apr; 29(3):197-204. PubMed ID: 30758986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypothermia Associated With Paliperidone Depot Injection in Schizophrenia Patient: A Case Report.
    Hirapara K; Munir A; Aggarwal R
    J Clin Psychopharmacol; 2020; 40(1):86-87. PubMed ID: 31834087
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.